68Ga-PSMA PET/CT 检出无症状前列腺癌脑转移
本文报道一例 66 岁无症状男性,在 68Ga-PSMA PET/CT 上偶然检出脑转移,后经活检证实为前列腺腺癌。随着新型雄激素剥夺药物和影像能力提高使平均生存期延长、脑转移发生率增加,临床需在无症状男性中也考虑这一鉴别诊断。
要点
- 前列腺癌脑转移罕见且多发生于病程晚期,通常伴神经系统表现。
- 68Ga-PSMA PET/CT 可偶然检出无症状前列腺癌脑转移。
- 新型雄激素剥夺药物和影像进步延长生存,脑转移发生率可能增加。
核心结论
- 前列腺癌脑转移罕见且见于病程晚期,但可在无症状男性中经 68Ga-PSMA PET/CT 偶然检出并经活检证实为前列腺腺癌。
研究设计与样本
- 本文为单例病例报告,报道一名 66 岁无症状男性。
主要发现
- 该 66 岁无症状男性在 68Ga-PSMA PET/CT 上偶然检出脑转移,后经活检证实为前列腺腺癌。
临床怎么用
- 随着新型雄激素剥夺药物和影像能力提高使平均生存期延长、脑转移发生率增加,对无症状男性也应考虑前列腺癌脑转移这一鉴别诊断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Brain metastases from prostate cancer are rare and occur at a late stage in the natural history of the disease. Men usually present with neurological manifestations. We present a 66-year-old asymptomatic man who had incidental brain metastases detected on Ga-PSMA PET/CT, which was later confirmed on biopsy to be prostate adenocarcinoma. With newer androgen deprivation agents and improved imaging capabilities increasing the mean survival and thus the incidence of brain metastases from prostate cancer, it is important to consider this important differential not only in men who display neurological symptoms but also in men who are asymptomatic.
引用
- Yin C, Ho B, Chan L, et al. Asymptomatic Prostate Cancer Brain Metastases on 68Ga-PSMA PET/CT. Clin Nucl Med. 2019. PMID: 30985411. doi:10.1097/RLU.0000000000002548
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。